The effect of ginseng on fatigue in neuromyelitis optica spectrum disorder

The effect of ginseng in fatigue related to neuromyelitis optica spectrum disorder: a double-blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200713048095N1

Enrollment

Registered

2020-08-07

Start date

2019-03-21

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatigue in Neuromyelitis optica spectrum disorder (NMOSD). Neuromyelitis optica [Devic]

Interventions

Intervention 1: Intervention group: will receive Ginseng 250-mg oral tablets twice a day for 3 months. medication is made by "Gol Daroo" company. Intervention 2: Control group: will receive placebo re

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 2015 diagnostic criteria for neuromyelitis optica spectrum disorder

Exclusion criteria

Exclusion criteria: pregnancy Concomitant use of anti-fatigue medications Having concomitant diseases effecting fatigue

Design outcomes

Primary

Measure	Time frame
Severity of fatigue in Fatigue Severity Scale questionnaire. Timepoint: evaluation of fatigue before intervention and 90 days after administering ginseng or placebo. Method of measurement: Fatigue Severity Scale questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact?Abdorreza Naser Moghadasi

Tehran University of Medical Sciences

moghaddasi@sina.tums.ac.ir+98 21 6634 8572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026